Literature DB >> 21116717

Mutational analysis of the PTEN gene and its effects in esophageal squamous cell carcinoma.

Guiqin Hou1, Zhaoming Lu, Mingyue Liu, Hongmin Liu, Lexun Xue.   

Abstract

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most frequently diagnosed cancers in China, but the etiology and mode of carcinogenesis of this disease remain poorly understood. The phosphatase and tensin homolog deleted from chromosome 10 (PTEN) with putative tumor suppressing is frequently mutated in many cancers. AIMS: The aim of this study was to investigate whether there exists a mutation in the PTEN gene of the ESCC cells, and the effects of the wild type and mutated PTEN genes on the proliferation and apoptosis of the ESCC cells.
METHODS: The wild type and mutated PTEN genes were cloned from human placenta and ESCC cells, respectively, and their effects on the proliferation and apoptosis of the ESCC cells were investigated. Also, the relationship between the PTEN gene status and sensitivity of the EC9706 cells to cisplatin was determined in the xenografts of nude mice.
RESULTS: There were mutations in the PTEN gene from ESCC cells. The proliferation of the EC9706 cells was clearly inhibited by the wild type PTEN gene, but not by the mutated PTEN gene in vitro. Furthermore, the wild type PTEN gene inhibited the growth of transplantable tumor, induced cell apoptosis, and improved the sensitivity of the EC9706 cells to cisplatin in vivo.
CONCLUSION: The findings of the present study demonstrate that there are mutations in the PTEN gene of the ESCC cells and that the wild type PTEN gene has important effects on the ESCC cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21116717     DOI: 10.1007/s10620-010-1474-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts.

Authors:  H H Fiebig; D P Berger; B R Winterhalter; J Plowman
Journal:  Cancer Treat Rev       Date:  1990-09       Impact factor: 12.111

3.  Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.

Authors:  Y C Hu; K Y Lam; J C Tang; G Srivastava
Journal:  Mol Pathol       Date:  1999-12

4.  Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.

Authors:  Carolyn Cao; Ty Subhawong; Jeffrey M Albert; Kwang Woon Kim; Ling Geng; Konjeti R Sekhar; Young Jin Gi; Bo Lu
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

5.  Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

Authors:  M S Neshat; I K Mellinghoff; C Tran; B Stiles; G Thomas; R Petersen; P Frost; J J Gibbons; H Wu; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.

Authors:  Panomwat Amornphimoltham; Vyomesh Patel; Akrit Sodhi; Nikolaos G Nikitakis; John J Sauk; Edward A Sausville; Alfredo A Molinolo; J Silvio Gutkind
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

Authors:  D H Teng; R Hu; H Lin; T Davis; D Iliev; C Frye; B Swedlund; K L Hansen; V L Vinson; K L Gumpper; L Ellis; A El-Naggar; M Frazier; S Jasser; L A Langford; J Lee; G B Mills; M A Pershouse; R E Pollack; C Tornos; P Troncoso; W K Yung; G Fujii; A Berson; P A Steck
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

8.  Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China.

Authors:  D Chang; T-Y Wang; H-C Li; J-C Wei; J-X Song
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

9.  PTEN polymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of China.

Authors:  H Ge; Y Y Cao; L Q Chen; Y M Wang; Z F Chen; D G Wen; X F Zhang; W Guo; N Wang; Y Li; J H Zhang
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

Review 10.  Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.

Authors:  K M Yamada; M Araki
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  7 in total

1.  Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation.

Authors:  Xiaobin Chang; Jimin Zhao; Fang Tian; Yanan Jiang; Jing Lu; Junfen Ma; Xiaoyan Zhang; Guoguo Jin; Youtian Huang; Zigang Dong; Kangdong Liu; Ziming Dong
Journal:  Oncol Lett       Date:  2016-07-25       Impact factor: 2.967

Review 2.  Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma.

Authors:  Rong Qiu; Wenxi Wang; Juan Li; Yuxiang Wang
Journal:  Mol Biol Rep       Date:  2022-03-17       Impact factor: 2.742

3.  Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma.

Authors:  Min Li; Huawen Sun; Lujun Song; Xiaodong Gao; Wenju Chang; Xinyu Qin
Journal:  Oncol Lett       Date:  2012-09-21       Impact factor: 2.967

4.  Prognostic implications of phosphatidylinositol 3-kinase/AKT signaling pathway activation in gastric carcinomas.

Authors:  Paula Blandina Ola Chiappini; Ivan Ucella Dantas de Medeiros; Luiz Guilherme Cenaglia Lima; Jose Humberto Fregnani; Suely Nonogaki; Wilson Luiz da Costa; Felipe Jose Fernandez Coimbra; Milton Jose de Barros E Silva; Celso Abdon Lopes de Mello; Clovis Antonio Lopes Pinto; Maria Dirlei Begnami
Journal:  Arch Med Sci       Date:  2016-06-07       Impact factor: 3.318

5.  High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus.

Authors:  Zhimin Zhang; Hualiang Xiao; Fei Xie; Hui Zhang; Chuan Chen; He Xiao; Zhenzhou Yang; Dong Wang; Zengpeng Li; Ge Wang
Journal:  BMC Cancer       Date:  2014-01-14       Impact factor: 4.430

6.  Targeted inhibition of mTOR signaling improves sensitivity of esophageal squamous cell carcinoma cells to cisplatin.

Authors:  Guiqin Hou; Shuai Yang; Yuanyuan Zhou; Cong Wang; Wen Zhao; Zhaoming Lu
Journal:  J Immunol Res       Date:  2014-04-10       Impact factor: 4.818

7.  Overexpression of LRIG1 regulates PTEN via MAPK/MEK signaling pathway in esophageal squamous cell carcinoma.

Authors:  Xiaofang Jiang; Huiwu Li
Journal:  Exp Ther Med       Date:  2016-08-22       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.